Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults — Stella

Home/Dientamoeba Fragilis Infection/

View on ClinicalTrials.gov

Recruiting

Back to Dientamoeba Fragilis Infection trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Israel

Sheba medical center, Ramat Gan, Israel

Key details

Sponsor

Sheba Medical Center

Enrollment target

~60 participants

Started

January 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.